Organon (OGN) Receivables - Net (2020 - 2026)
Organon (OGN) posted Receivables - Net of $1.5 billion for Q2 2026, up 7.8% on a QoQ basis from $1.4 billion in Q1 2026, and up 0.54% year-over-year from $1.5 billion in Q2 2025.
Analysis
Organon (OGN) Receivables - Net (2020 - 2026) Analysis & Trends
Organon has reported Receivables - Net for 7 years, with the latest figure at $1.5 billion in Q2 2026.
- On a quarterly basis, Receivables - Net rose 0.54% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 0.54% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 1.99% from the prior year.
- Receivables - Net was $1.5 billion for Q2 2026 at Organon, up from $1.4 billion in the prior quarter.
- The five-year high for Receivables - Net was $1.7 billion in Q4 2023, with the low at $1.3 billion in Q1 2022.
- Average Receivables - Net over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net surged 30.89% in 2022, then retreated 22.13% in 2024.
- Over 5 years, Receivables - Net stood at $1.5 billion in 2022, then increased by 18.24% to $1.7 billion in 2023, then decreased by 22.13% to $1.4 billion in 2024, then decreased by 1.99% to $1.3 billion in 2025, then advanced by 12.1% to $1.5 billion in 2026.
- The last three Receivables - Net figures came in at $1.5 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.38 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Sep 30, 2023 | 1.65 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.45 Bn |
| Dec 31, 2022 | 1.48 Bn |
| Sep 30, 2022 | 1.44 Bn |
| Jun 30, 2022 | 1.49 Bn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 1.38 Bn |
| Sep 30, 2021 | 1.50 Bn |